Pathfinder

Lipid Nanoparticles vs. Viral Vectors for Gene Delivery: Which Platform Is Better?

Pharma's Almanac

Continuous VV

The Stepwise Future of Continuous Viral Vector Manufacturing

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

AAV vs. Lentiviral Vectors: Which Viral Vector Is Better for Gene Therapy?

Pharma's Almanac

Pathfinder

CHO vs. HEK293: Which Expression System Is Better for Biopharmaceutical Production?

Pharma's Almanac

AAV Rare Disease

Scarcity by Design: The Manufacturing Reality of AAV Gene Therapies for Rare Indications

David Alvaro, Ph.D.

Pharma's Almanac

Viral Vectors

Transformative Advances in Viral Vector Manufacturing: Unlocking Commercial Scalability, Consistency, and Cost-Effectiveness

Susan D'Costa, Ph.D.

Genezen

Gene Therapy

Build Backwards: A Framework for Rare Disease Gene Therapy Development

Farzin Farzaneh, Ph.D.; Nicholas Ostrout, Ph.D.

ViroCell Biologics

Viral Vectors

De-Risking Cell and Gene Therapies with Innovative Solutions: A Review for Leveraging a Proven Workhorse Technology in New Ways

Farzin Farzaneh, Ph.D.; Nicholas Ostrout, Ph.D.; Glenda Dickson, Ph.D.; David Darling, Ph.D.

ViroCell Biologics

Viral Vectors

Backbone of Innovation: How CDMO Vector Platforms Are Accelerating Gene Therapy Development

David Alvaro, Ph.D.

Pharma's Almanac

Viral Vector CDMOs

Breaking Through the Noise in Viral Vector CDMO Marketing

Emilee Kudla

Pharma's Almanac

Neuroscience

Designer Control: DREADDs and the Next Generation of Targeted Neuromodulation

David Alvaro, Ph.D.

Pharma's Almanac

AAV

Gene Therapy at a Crossroads: Rethinking AAV Amid Industry Resets

Daniel Smith, Ph.D.

Nice Consulting

Nonviral Delivery

Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA

Lisa Caproni

Touchlight

AAV Quality

Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation

Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.

Rentschler Biopharma SE

CDMO

Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO

Janet Hoogstraate, Ph.D.

NorthX Biologics

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Tom Adie, Ph.D.; Elena Stoyanova, Ph.D.

Touchlight

dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

Jill Makin

Touchlight